China Jo-Jo Drugstores
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of China Jo-Jo Drugstores generated cash of -$3,155,439, which is more than the previous year. Cash used in financing activities reached the amount of $8,004,291 last year. Net change in cash is therefore $1,303,526.
Cash Flow
| 2015 | 1.06M | -4.36M | 2.86M |
|---|---|---|---|
| 2016 | 2.58M | 429.80K | -401.89K |
| 2017 | 1.55M | -46.54K | 10.64M |
| 2018 | -2.07M | -2.97M | -770.93K |
| 2019 | -5.60M | -7.32M | 8.07M |
| 2020 | -6.90M | -4.83M | 19.01M |
| 2021 | -62.29K | -1.99M | 3.07M |
| 2022 | -5.38M | -306.13K | 4.83M |
| 2023 | -3.28M | -316.09K | 2.36M |
| 2024 | -3.15M | -2.03M | 8.00M |
CJJD Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 31.57M | 35.33M | 34.67M | 30.98M | 24.74M | 31.45M | 18.36M | 6.67M | 4.02M | 4.44M |
Operating activities | ||||||||||
Net income | -4.23M | -21.13M | -3.19M | -8.37M | -6.45M | -1.31M | -17.05M | -5.64M | 447.15K | 855.62K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 5.38M | 718.00K | 1.25M | 1.75M | 2.08M | 1.67M | 1.38M | 1.31M | 1.45M | 2.82M |
Stock-based compensation expense | 0 | 10.36M | 0 | 3.94M | 34.56K | 197.1K | 7.02M | 2.24M | 1.02M | 1.00M |
| Deferred income tax benefit | 0 | 10.36M | 0 | 3.94M | 34.56K | 197.1K | 7.02M | 2.24M | 1.02M | 1.00M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -2.45M | -2.53M | -2.65M | -3.30M | -1.56M | -116.81K | -2.07M | -717.38K | 432.67K | -410.49K |
Inventories | -2.53M | -522.55K | 1.52M | -3.61M | 979.93K | -1.39M | -2.41M | 191.56K | -762.21K | -2.97M |
Accounts payable | 6.00M | 1.76M | -3.55M | 6.38M | -317.75K | -528.35K | 3.72M | 3.93M | 1.59M | 1.25M |
Cash generated by operating activities | -3.15M | -3.28M | -5.38M | -62.29K | -6.90M | -5.60M | -2.07M | 1.55M | 2.58M | 1.06M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -4.37K | 0 | 97.80K | 871.14K | -104.36K | -75.51K | -89.19K | 0 | -1.30M |
Investments In Property Plant And Equipment | -856.66K | -311.71K | -306.13K | -604.17K | -2.28M | -7.30M | -2.90M | -411.19K | -250.31K | -3.05M |
Acquisitions Net | -1.11M | -4.37K | 0 | -1.47M | -2.56M | 29.81K | 0 | 7.87K | -110.71K | -1.58M |
Cash generated by investing activities | -2.03M | -316.09K | -306.13K | -1.99M | -4.83M | -7.32M | -2.97M | -46.54K | 429.80K | -4.36M |
Financing activities | ||||||||||
Common Stock Issued | 2.58M | 7.32M | 0 | 9.28M | 9.27M | 7.52K | 0 | 10.64M | 2.69M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 4.15M | -4.12M | 4.14M | -55.24M | -47.56M | 8.01M | -22.47M | -3.89M | -18.98M | 7.41M |
Cash used in financing activities | 8.00M | 2.36M | 4.83M | 3.07M | 19.01M | 8.07M | -770.93K | 10.64M | -401.89K | 2.86M |
Net Change In Cash | 1.30M | -3.76M | 666.93K | 3.69M | 6.23M | -6.70M | -3.23M | 11.69M | 2.64M | -421.69K |
Cash at end of period | 32.87M | 31.57M | 35.33M | 34.67M | 30.98M | 24.74M | 15.13M | 18.36M | 6.67M | 4.02M |
| Data source | Data source | Data source |